Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00501696 (ClinicalTrials.gov)	February 2007	12/7/2007	A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone	A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone on Quality of Life as Measured by the Multiple Sclerosis Quality of Life Inventory (MSQLI54)	Multiple Sclerosis	Drug: 4.5 mg Naltrexone;Drug: Naltrexone	University of California, San Francisco	NULL	Completed	18 Years	86 Years	Both	80	Phase 3	United States
2	EUCTR2005-005679-13-IT (EUCTR)	28/06/2006	23/06/2006	An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis. - ND	An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis. - ND	multiple sclerosis MedDRA version: 6.1;Level: PT;Classification code 10053395	INN or Proposed INN: Naltrexone	OSPEDALE S. RAFFAELE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40		Italy